Press "Enter" to skip to content

Marksans Pharma gets EIR from USFDA for its Goa facility

The Mumbai-headquartered firm is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets.

Original source: https://health.economictimes.indiatimes.com/news/pharma/marksans-pharma-gets-eir-from-usfda-for-its-goa-facility/69676475?utm_source=RSS&utm_medium=ETRSS

Also Read:   Taiho Pharmaceuticals moves US court against Natco on generic cancer drug